Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

888 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
TCERG1L allelic variation is associated with cisplatin-induced hearing loss in childhood cancer, a PanCareLIFE study.
Meijer AJM, Diepstraten FA, Langer T, Broer L, Domingo IK, Clemens E, Uitterlinden AG, de Vries ACH, van Grotel M, Vermeij WP, Ozinga RA, Binder H, Byrne J, van Dulmen-den Broeder E, Garrè ML, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, Kepakova K, Tissing WJE, van der Kooi ALF, Kremer LCM, Kruseova J, Pluijm SMF, Kuehni CE, van der Pal HJH, Parfitt R, Spix C, Tillmanns A, Deuster D, Matulat P, Calaminus G, Hoetink AE, Elsner S, Gebauer J, Haupt R, Lackner H, Blattmann C, Neggers SJCMM, Rassekh SR, Wright GEB, Brooks B, Nagtegaal AP, Drögemöller BI, Ross CJD, Bhavsar AP, Am Zehnhoff-Dinnesen AG, Carleton BC, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE Consortium; and the CPNDS Consortium. Meijer AJM, et al. Among authors: langer t. NPJ Precis Oncol. 2021 Jul 14;5(1):64. doi: 10.1038/s41698-021-00178-z. NPJ Precis Oncol. 2021. PMID: 34262104 Free PMC article.
The influence of genetic variation on late toxicities in childhood cancer survivors: A review.
Clemens E, van der Kooi ALF, Broer L, van Dulmen-den Broeder E, Visscher H, Kremer L, Tissing W, Loonen J, Ronckers CM, Pluijm SMF, Neggers SJCMM, Zolk O, Langer T, Zehnhoff-Dinnesen AA, Wilson CL, Hudson MM, Carleton B, Laven JSE, Uitterlinden AG, van den Heuvel-Eibrink MM. Clemens E, et al. Among authors: langer t. Crit Rev Oncol Hematol. 2018 Jun;126:154-167. doi: 10.1016/j.critrevonc.2018.04.001. Epub 2018 Apr 12. Crit Rev Oncol Hematol. 2018. PMID: 29759558 Free article. Review.
Genetic variation of cisplatin-induced ototoxicity in non-cranial-irradiated pediatric patients using a candidate gene approach: The International PanCareLIFE Study.
Clemens E, Broer L, Langer T, Uitterlinden AG, de Vries ACH, van Grotel M, Pluijm SFM, Binder H, Byrne J, Broeder EVD, Crocco M, Grabow D, Kaatsch P, Kaiser M, Kenborg L, Winther JF, Rechnitzer C, Hasle H, Kepak T, van der Kooi AF, Kremer LC, Kruseova J, Kuehni CE, van der Pal H, Parfitt R, Deuster D, Matulat P, Spix C, Tillmanns A, Tissing WJE, Maier L, Am Zehnhoff-Dinnesen A, Zolk O, van den Heuvel-Eibrink MM; PanCareLIFE consortium. Clemens E, et al. Among authors: langer t. Pharmacogenomics J. 2020 Apr;20(2):294-305. doi: 10.1038/s41397-019-0113-1. Epub 2019 Oct 31. Pharmacogenomics J. 2020. PMID: 31666714
Cardiovascular Health Status And Genetic Risk In Survivors of Childhood Neuroblastoma and Nephroblastoma Treated With Doxorubicin: Protocol of the Pharmacogenetic Part of the LESS-Anthra Cross-Sectional Cohort Study.
Zolk O, von dem Knesebeck A, Graf N, Simon T, Hero B, Abdul-Khaliq H, Abd El Rahman M, Spix C, Mayer B, Elsner S, Gebauer J, Langer T. Zolk O, et al. Among authors: langer t. JMIR Res Protoc. 2022 Feb 17;11(2):e27898. doi: 10.2196/27898. JMIR Res Protoc. 2022. PMID: 35175211 Free PMC article.
The chance of transition: strategies for multidisciplinary collaboration.
Gebauer J, Skinner R, Haupt R, Kremer L, van der Pal H, Michel G, Armstrong GT, Hudson MM, Hjorth L, Lehnert H, Langer T. Gebauer J, et al. Among authors: langer t. Endocr Connect. 2022 Aug 11;11(9):e220083. doi: 10.1530/EC-22-0083. Print 2022 Sep 1. Endocr Connect. 2022. PMID: 35900792 Free PMC article. Review.
IT-Related Barriers and Facilitators to the Implementation of a New European eHealth Solution, the Digital Survivorship Passport (SurPass Version 2.0): Semistructured Digital Survey.
de Beijer IAE, van den Oever SR, Charalambous E, Cangioli G, Balaguer J, Bardi E, Alfes M, Cañete Nieto A, Correcher M, Pinto da Costa T, Degelsegger-Márquez A, Düster V, Filbert AL, Grabow D, Gredinger G, Gsell H, Haupt R, van Helvoirt M, Ladenstein R, Langer T, Laschkolnig A, Muraca M, Pluijm SMF, Rascon J, Schreier G, Tomášikova Z, Trauner F, Trinkūnas J, Trunner K, Uyttebroeck A, Kremer LCM, van der Pal HJH, Chronaki C; PanCareSurPass Consortium. de Beijer IAE, et al. Among authors: langer t. J Med Internet Res. 2024 May 2;26:e49910. doi: 10.2196/49910. J Med Internet Res. 2024. PMID: 38696248 Free article.
CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group.
Hertzberg H, Huk WJ, Ueberall MA, Langer T, Meier W, Dopfer R, Skalej M, Lackner H, Bode U, Janssen G, Zintl F, Beck JD. Hertzberg H, et al. Among authors: langer t. Med Pediatr Oncol. 1997 Jun;28(6):387-400. doi: 10.1002/(sici)1096-911x(199706)28:6<387::aid-mpo1>3.0.co;2-c. Med Pediatr Oncol. 1997. PMID: 9143382
Over 15 years of ELTEC: A report of the international BFM study group.
Paulides M, Haupt R, Jankovic M, Möricke A, Langer T, Beck JD; ELTEC GroupELTEC members: E. Frey, H. Lackner, A. Moser, Austria; R. Maurus, J. Otten, P. Philippet, Belgium; J.D. Beck, G. Calaminus, H.G. Dörr, T. Langer, A. Möricke, M. Paulides, T. Rau, Germany; M.M. Hawkins, A. Taylor, Great Britain; E. Magyarosy, Hungary; E. Castagnola, A. Colombini, F. Fioredda, R. Haupt (Chairman), M. Jankovic, C. Manganini (Secretary), C. Micalizzi, P. Reciputo, M.G. Valsecchi, Italy; J.P.M. Bökkerink, W. Tissing, The Netherlands; A. Feldges, J. Greiner, Swit. Paulides M, et al. Among authors: langer t. Pediatr Blood Cancer. 2007 Jul;49(1):113-4; discussion 112. doi: 10.1002/pbc.21087. Pediatr Blood Cancer. 2007. PMID: 17066469 No abstract available.
888 results